Search
01/06/2022
Discontinuation of maintenance electroconvulsive therapy: Lessons learned from the COVID-19 pandemic
Martinez-Amoros, E, Serra, P, Bassa, A, Palao, DJ, Cardoner, N. Discontinuation of maintenance electroconvulsive therapy: Lessons learned from the COVID-19 pandemic. SPANISH JOURNAL OF PSYCHIATRY AND MENTAL HEALTH. 2022; 15(2)DOI:10.1016/j.rpsm.2021.07.005. PMID:34329756. IF:9.200(Q1/1D).
05/04/2022
Barriers, facilitators, and proposals for improvement in the implementation of a collaborative care program for depression: a qualitative study of primary care physicians and nurses
Aragones, E, Lopez-Cortacans, G, Cardoner, N, Tome-Pires, C, Porta-Casteras, D, Palao, D. Barriers, facilitators, and proposals for improvement in the implementation of a collaborative care program for depression: a qualitative study of primary care physicians and nurses. BMC HEALTH SERVICES RESEARCH. 2022; 22(1)DOI:10.1186/s12913-022-07872-z. PMID:35382822. IF:2.800(Q3/6D).
01/01/2022
Advancing the treatment of long-lasting borderline personality disorder: a feasibility and acceptability study of an expanded DBT-based skills intervention
Soler J., Casellas-Pujol E., Pascual J.C., Schmidt C., Domínguez-Clavé E., Cebolla A., Alvear D., Muro A., Elices M.. Advancing the treatment of long-lasting borderline personality disorder: a feasibility and acceptability study of an expanded DBT-based skills intervention. Borderline Personality Disorder and Emotion Dysregulation. 2022; 9(1)DOI:10.1186/s40479-022-00204-x. PMID:36503564. IF:4.100(Q2/5D).
01/01/2022
Epigenetic clocks in relapse after a first episode of schizophrenia
Segura À.-G., Prohens L., Mezquida G., Amoretti S., Bioque M., Ribeiro M., Gurriarán-Bas X., Rementería L., Berge D., Rodriguez-Jimenez R., Roldán A., Pomarol-Clotet E., Ibáñez A., Usall J., García-Portilla M.P., Cuesta M.J., Parellada M., González-Pinto A., Berrocoso E., Bernardo M., Mas S., González-Díaz J.M., Arbelo N., González-Peñas J., Pina-Camacho L., Diestre A., Selma J., Zorrilla I., López P., Trabsa A., Monserrat C., Sanchez-Pastor L., Nuñez-Doyle A., Fatjó-Vilas M., Sarró S., Butjosa A., Pardo M., López-Ilundain J.M., Sánchez Torres A.M., Saiz-Ruiz J., Ochoa-Mangado E., RIevero O., De-la-Cámara C., Echevarría R.S., González-Blanco L.. Epigenetic clocks in relapse after a first episode of schizophrenia. SCHIZOPHRENIA. 2022; 8(1)DOI:10.1038/s41537-022-00268-2. PMID:35869075. IF:5.400(Q2/3D).
01/01/2022
The effect of early life events on glucose levels in first-episode psychosis
Garcia-Rizo C., Cabrera B., Bioque M., Mezquida G., Lobo A., Gonzalez-Pinto A., Diaz-Caneja C.M., Corripio I., Vieta E., Baeza I., Garcia-Portilla M.P., Gutierrez-Fraile M., Rodriguez-Jimenez R., Garriga M., Fernandez-Egea E., Bernardo M.. The effect of early life events on glucose levels in first-episode psychosis. Frontiers in Endocrinology. 2022; 13DOI:10.3389/fendo.2022.983792. PMID:36545332. IF:5.200(Q1/3D).
01/01/2022
The influence of modifiable cardiovascular risk factors on cognition, functioning, and inflammatory markers in first-episode psychosis: Results from a 2-year follow-up study
Pujol N., Bergé D., Mané A., Bioque M., Mezquida G., Amoretti S., Baeza I., González-Pinto A., Lobo A., Cuesta M.J., Ribeiro M., Sánchez-Tomico G., Pérez-Solà V., Verdolini N., Vieta E., Parellada M., Roldán A., Bernardo M.. The influence of modifiable cardiovascular risk factors on cognition, functioning, and inflammatory markers in first-episode psychosis: Results from a 2-year follow-up study. PSYCHIATRY RESEARCH. 2022; 316DOI:10.1016/j.psychres.2022.114760. PMID:35977447. IF:11.300(Q1/1D).